seed
Stage
About
Affirma Biotech develops new orally available immunostimulatory drugs to treat severe respiratory infections, focusing on enhancing immune response in hospitalized patients with diseases like influenza and community-acquired pneumonia.
Explore Affirma Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.